Summary by Moomoo AI
On December 11, 2024, FOSUN PHARMA signed multiple framework agreements with its controlling shareholder FOSUN INTL, involving ongoing related transactions for the fiscal year 2025. These include a leasing framework agreement and a mutual supply framework agreement, both effective from January 1, 2025, to December 31, 2025.The leasing framework agreement consists of two parts: lessee and lessor. The annual limit for the lessee framework agreement is 80 million RMB, while the annual limit for the lessor framework agreement is 10 million RMB. The mutual supply framework agreement between FOSUN INTL involves both parties providing products and services to each other, with a total annual limit of 205 million RMB.According to the Hong Kong listing rules, the transactions under these agreements constitute ongoing related transactions. Since the highest applicable...Show More
